The aim of this study was to investigate the S-layer proteins (SLPs) of the hypervirulent Clostridium difficile PCR ribotype 027 and compare them with those of PCR ribotype 001 and other PCR ribotypes involved in C. difficile infection and outbreaks, by molecular analysis and immunological assays. It has been demonstrated previously that PCR ribotype 027 SlpA is conserved in C. difficile strains belonging to this PCR ribotype and that it is a new variant, showing 88 % identity with SlpA of PCR ribotype 001. As the low-molecular-weight (LMW) SLPs of C. difficile are immunodominant antigens, attention was focused on this region of the genome. Sequencing of strains of different PCR ribotypes (001, 012, 014, 017, 027 and 078) showed that SlpA was conserved among strains belonging to the same PCR ribotype. Comparison of the LMW SLP region among these strains identified ten regions with sequence identity between PCR ribotypes 027 and 001, and low conservation with the other PCR ribotypes. In particular, two of these regions corresponded to areas predicted to be surface exposed. Three specific peptides, including those of the two surface-exposed regions, were recognized by human sera against PCR ribotypes 027 and 001 and by a rabbit polyclonal serum against the SLPs of PCR ribotype 027. In contrast, these peptides were not recognized by a polyclonal serum against the SLPs of PCR ribotype 012 used as a control. These results confirm the antigenic role of the LMW SLP and suggest that it may have a role in evasion of the host immune response.
INTRODUCTION
Although two large proteins, toxin A (TcdA) and toxin B (TcdB), are recognized as the principal virulence factors of Clostridium difficile, a number of additional factors have been suggested to play a role in infection, including flagella, fimbriae, degradative enzymes and cell-surface proteins Sára & Sleytr, 2000; Tasteyre et al., 2001; Waligora et al., 2001 ).
The surface (S) layer is a predominantly surface-associated crystalline or paracrystalline array, composed of identical protein or glycoprotein subunits, found in many prokaryotes (Sára & Sleytr, 2000) . Previous studies have shown that C. difficile expresses on its surface two superimposed and structurally different S-layer lattices: the inner is arranged in a hexagonal symmetry, whereas the outer has a square symmetry (Cerquetti et al., 2000) . Biochemical characterization of isolated S-layer proteins (SLPs) from different C. difficile strains has demonstrated that each layer is composed of a distinct protein subunit that displays a slight variation in molecular mass among strains: the high-molecular-weight (HMW) SLP (~40 kDa) and the low-molecular-weight (LMW) SLP (~35 kDa) (Calabi et al., 2001; Cerquetti et al., 2000) . These proteins have been demonstrated not to be glycosylated in strains representing different PCR ribotypes . Both SLPs are encoded by a single gene, slpA, and are produced from the post-translational cleavage of a common precursor: the HMW SLP is derived from the Cterminal portion of the precursor, whereas the LMW SLP is derived from the N-terminal portion (Calabi et al., 2001) . Sequence variability is particularly evident in the LMW SLP but is also present in the HMW SLP, giving rise to a range of protein sizes Eidhin et al., 2006) . Studies on S-layer adhesive properties have demonstrated that chemical removal of the SLPs or treatment with anti-SLP antibodies can abolish adherence of C. difficile to human HeLa or mouse 929 cells . The specific binding of purified C. difficile SLPs to both gastrointestinal tissues and several extracellular matrix proteins has also been demonstrated . The HMW SLP appears to be immunologically conserved among strains (Cerquetti et al., 2000; Takeoka et al., 1991) , whereas the LMW SLP is less conserved. The LMW SLP is an immunodominant antigen and, in fact, is recognized the most consistently by specific antibodies from sera of patients infected by C. difficile (Pantosti et al., 1989) .
In the present study, we investigated the SLPs of the hypervirulent C. difficile PCR ribotype 027 and compared them with those of PCR ribotype 001 and other PCR ribotypes involved in C. difficile infection (CDI) and outbreaks, by molecular analysis and immunological assays.
METHODS
C. difficile strains and typing. Fifteen C. difficile strains belonging to different PCR ribotypes were used in this study. The characteristics of these strains are shown in Table 1 . Strains were cultured under anaerobic conditions on Brucella agar plates containing vitamin K 1 (0.5 mg l 21 ), haemin (5 mg l
21
) and 5 % defibrinated sheep red blood cells and in brain-heart infusion (BHI) broth (Oxoid) for SLP extraction.
Typing of C. difficile strains was performed by PCR ribotyping using the method of Bidet et al. (1999) . The genomic DNA fingerprinting patterns produced by PCR ribotyping were compared and analysed using GelCompar II version 6.0 (Applied Maths). DNA fingerprinting patterns produced by PCR ribotyping were compared with those of a collection of the predominant PCR ribotypes circulating in Europe. This collection of strains was kindly supplied by Dr Ed Kuijper (on behalf of the European Centre for Disease Prevention and Control, Stockholm, Sweden).
SDS-PAGE. SLPs were obtained by low-pH glycine extraction (Calabi et al., 2001) . Briefly, a 24 h culture in BHI broth was centrifuged at 4500 g for 15 min and washed twice with PBS. The pellet was treated with 0.2 M glycine (pH 2.2). After 15 min incubation at room temperature, the mixture was centrifuged and the supernatant was neutralized with 2 M Tris and separated by SDS-PAGE, using a 12 % gel, following the Laemmli system (Sambrook et al., 1989) . After electrophoresis, the gel was rinsed in H 2 O and stained with Coomassie Brilliant Blue to visualize the proteins.
Sequence analysis. A set of primers was used to amplify the slpA gene of C. difficile strains ( Table 2 ). PCR conditions were: 94 uC for 5 min, followed by 30 cycles of 94 uC for 1 min, 46-48 uC (depending on the melting temperature of the primers) for 1 min and 72 uC for 1 min, with a final extension at 72 uC for 5 min.
Nucleotide sequence analysis was performed using Lasergene version 8.0 software (DNASTAR), the National Center for Biotechnology Information BLAST server (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the European Bioinformatics Institute CLUSTAL W server (http://www. ebi.ac.uk/Tools/msa/clustalw2/).
Visualization of the LMW SLP structure (LMW SLP 1-262 ) for identification of surface-exposed regions was performed using the Swiss-PDB Viewer for the published crystal structure (PDB no. 3CVZ) (Fagan et al., 2009 ).
Human and rabbit sera. Human sera were obtained from two patients at the Brussels St Luc University Hospital, Brussels, Belgium, who were infected with C. difficile strains belonging to PCR ribotypes 027 and 001, respectively. The PCR ribotype 027 serum was collected in 2009 from a patient chronically positive for C. difficile PCR ribotype 027 since 2008. The PCR ribotype 001 serum was collected in 2010 from a patient who had one CDI episode during his hospitalization for pancreatitis.
As it was not possible to obtain sera from patients infected by C. difficile strains other than PCR ribotypes 027 and 001, polyclonal antibodies against the SLPs of the PCR ribotype 012 C. difficile C253 clinical isolate (Cerquetti et al., 2000) were prepared in adult rabbits by Primm Srl, Milan, Italy, using as antigen both the HMW and LMW protein bands excised from an SDS-PAGE gel. Each animal received four doses of antigen: the first immunization with 200 mg in complete Freund's adjuvant and the other three at days 21, 28 and 35 with 200, 100 and 100 mg in incomplete Freund's adjuvant, respectively. The same procedure was used to prepare polyclonal antibodies against the SLPs of PCR ribotype 027 C. difficile R20291.
Rabbit pre-immune serum and a commercial human serum (type AB; Euroclone) were used as negative controls.
Peptide synthesis and immunodetection. For dot blot analysis, 11 synthetic peptides from the SlpA variable region were synthesized by Invitrogen (Table 3) . Chemical activation of nitrocellulose membranes was performed following the procedure described by Másson et al. (1993) . Briefly, membranes were treated with 2.5 % 1,6-diaminohexane solution (pH 11.9) for 30 min, washed for 24 h with H 2 O and activated with 1 % glutaraldehyde, 0.5 M NaHCO 3 /Na 2 CO 3 (pH 10) for 30 min. The membranes were then washed for 3 h with H 2 O and 10 mg each peptide was spotted on the activated nitrocellulose membrane.
Immunodetection was performed using sera from patients with severe CDI or sera from rabbits immunized with SLPs. Human sera were used at a 1 : 1000 dilution in 0.9 % NaCl/10 mM Tris/HCl buffer containing 3 % BSA and incubated for 2 h at room temperature. Detection was performed using a 1 : 2000 dilution of anti-human IgG (whole molecule) alkaline phosphatase conjugate (Sigma-Aldrich Biotechnology) and SigmaFast BCIP/NBT (Sigma-Aldrich Biotechnology) according to the manufacturer's instructions. Rabbit sera were used at 1 : 50 000 or 1 : 10 000 dilutions and detection was performed using a 1 : 2000 dilution of anti-rabbit IgG (whole molecule) alkaline phosphatase conjugate (Sigma-Aldrich Biotechnology).
RESULTS AND DISCUSSION
In the present study, SlpA of C. difficile PCR ribotype 027 was analysed and compared with that of five other PCR ribotypes (001, 012, 014, 017 and 078) that are frequently involved in sporadic CDI and outbreaks (Bauer et al., 2011) . We demonstrated previously that SlpA is conserved in C. difficile strains belonging to PCR ribotype 027 and that it is a new variant, showing 88 % identity to SlpA of PCR ribotype 001 (Spigaglia et al., 2011) .
We focused our attention on the LMW SLP of C. difficile as it has been demonstrated to be an immunodominant antigen (Pantosti et al., 1989) . et al. (2006) , by one amino acid substitution (Leu 211 ASer), whereas it was identical to that found in the C. difficile strain R13699, typed as PCR ribotype 066 in the same study. As strain R13699 was reported as non-toxigenic, although it is known that PCR ribotype 066 strains are toxigenic and belong to toxinotype V or VI, as reported by Rupnik et al. (2001) , it is likely that a mistake occurred in typing.
SlpA glycine extracts of the reference C. difficile strains representing the different PCR ribotypes were examined by Fig. 1 . Multiple alignments of the predicted amino acid sequences of the SlpA variable region from strains of PCR ribotypes 001, 012, 014, 017, 027 and 078. Numbers in parentheses show the nucleotide numbers taking missing nucleotides into account. The alignment was performed using SlpA variants representative of each PCR ribotype. One SlpA variant was identified in each PCR ribotype, except for PCR ribotype 014, for which two variants, SlpA-14a and SlpA-14b, were found. These variants differ by the amino acid substitution Leu 211 ASer. Blocks of conserved residues at a given position are highlighted in cyan, whilst consensus residues derived from the occurrence of .50 % of a single residue at a given position are highlighted in green. Residues conserved in all sequences are indicated by red text with yellow shading. Peptides showing sequence identity between PCR ribotypes 001 and 027 and low conservation with the other PCR ribotypes are underlined and numbered from 1 to 10. Peptide 11 is a sequence with 100 % identity among all PCR ribotypes. The two peptides of PCR ribotypes 001 and 027 with sequence identity that are predicted to be surface exposed are underlined in red. Diamonds indicate residues with high solvent accessibility.
SDS-PAGE. All strains showed two distinct SLPs, and the same pattern of proteins was observed for PCR ribotypes 027 and 001 (data not shown).
Multiple alignments of the predicted amino acid sequences of the LMW SLPs of C. difficile strains of PCR ribotypes 001, 012, 014, 017, 027 and 078 are shown in Fig. 1 . The SlpA sequence variant found in the C. difficile strains belonging to a certain PCR ribotype is denoted with the number of the PCR ribotype (SlpA-1 for PCR ribotype 001, etc.). The two SlpA variants identified in C. difficile strains belonging to PCR ribotypes 014 were denominated SlpA14a (strain R12885, DQ060638) and SlpA-14b (strains ATCC 43600, FII3 and IT0855). Ten regions with sequence identity between PCR ribotypes 027 and 001 but with low conservation with the other PCR ribotypes were identified. In particular, two of these regions corresponded to areas predicted to be surface exposed on the basis of the solvent accessibility data given for the single amino acids in the published crystal structure of LMW SLP 1-262 (Fagan et al., 2009) (Fig. 2) .
Synthetic peptides (numbered 1-10) were designed based on the ten regions with sequence identity between PCR ribotypes 027 and 001 (Table 3 and Fig. 1 ), whereas peptide 11 was designed based on a region conserved in all PCR ribotypes. Peptides 4, 5, 7 and 8 were recognized by human sera against PCR ribotype 027 or 001 (Fig. 3a) . The same peptides, except for peptide 5, were also recognized by the rabbit polyclonal serum against the SLPs of PCR ribotype 027 (Fig. 3b) . In contrast, peptides 2, 3, 5, 6 and 9 were recognized by the polyclonal serum against the SLPs of PCR ribotype 012 (Fig. 3b) . Only a very weak signal for peptide 2 was observed with both the rabbit pre-immune sera and a commercial human serum used as negative controls (data not shown). Recognition of peptides by a polyclonal serum raised against SlpA of PCR ribotype 012, whose sequence contains only stretches of low similarity, cannot easily be explained without further characterization. It is possible that this behaviour was simply due to the presence of antibodies that show low-specificity binding. It is noteworthy that peptides 1, 10 and 11 were not recognized by any of the sera. The former two peptides may not be accessible to the immune system when assembled to form the S layer, as it has been shown that the regions comprising these peptides are involved in the interaction between the LMW and HMW SLPs (Fagan et al., 2009) . Similarly, peptide 11, which represented a region of 100 % sequence identity among all PCR ribotypes, may be assigned to a domain of SlpA hidden within the S-layer structure and therefore not exposed to the immune system of the host. Alternatively, peptide 11 may belong to a region of the LMW protein showing low antigenicity. The reaction of both human sera from patients infected by C. difficile strains of PCR ribotypes 027 and 001 with the LMW proteins from strains of PCR ribotypes 027 and 001 confirmed the antigenic role of this Fig. 2 . Mapping of residues that are highly conserved and surface exposed in PCR ribotypes 001 and 027 onto the crystal structure of the LMW SLP . Conserved residues are shown in a surface representation superimposed onto a ribbon diagram of the structure. Residues predicted to have high surface accessibility are shown in yellow. Several of the most conserved residues have been labelled. Fig. 3 . Dot blot of synthetic peptides designed based on the LMW SLP regions with sequence identity between C. difficile PCR ribotypes 027 and 001. Peptides are indicated by the numbers 1-11 (see Table 3 ). (a) Peptides recognized by human serum obtained from a patient infected with C. difficile of PCR ribotype 027 (upper filter) or from a patient infected with C. difficile of PCR ribotype 001 (lower filter). (b) Peptides recognized by rabbit polyclonal serum against C. difficile PCR ribotype 027 SLPs (upper filter) or by rabbit polyclonal serum against C. difficile PCR ribotype 012 SLPs (lower filter).
protein. In addition, three regions of this protein, corresponding to residues 67-79, 174-186 and 216-229 of the SlpA sequence of strain R20291, were found to be immunodominant and recognized by both human sera against C. difficile PCR ribotype 027 or 001 and rabbit polyclonal serum against the SLPs of PCR ribotype 027. As antigenic variation of surface proteins is assumed to provide pathogenic bacteria the means to escape recognition by the immune system of the host, these results suggest that the variable regions of SlpA may have a role in evasion of the host immune response.
